The authors wish to clarify that the authors Aljosa Mandic, Katarina Koprivsek, and Goran Malenkovic are also affiliated with Faculty of Medicine Novi Sad, University of Novi Sad, Serbia, as well as Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia.
. 2020 Jul 7;57:102875. doi: 10.1016/j.ebiom.2020.102875
Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’
Suzy Scholl
a,⁎, Marina Popovic
b, Anne de la Rochefordiere
a, Elodie Girard
a, Sylvain Dureau
a, Aljosa Mandic
v, Katarina Koprivsek
b,v, Nina Samet
c, Marius Craina
d, Madalin Margan
d, Sanne Samuels
e, Henry Zijlmans
e, Gemma Kenter
e, Peter Hillemanns
f, Sorin Dema
d, Alis Dema
d, Goran Malenkovic
v, Branislav Djuran
b, Anne Floquet
g, Delphine Garbay
g, Frédéric Guyon
g, Pierre Emmanuel Colombo
h, Michel Fabbro
h, Christine Kerr
h, Charlotte Ngo
i, Fabrice Lecuru
i, Eleonor Rivin del Campo
j, Charles Coutant
k, Frédéric Marchal
l, Nathalie Mesgouez-Nebout
m, Virginie Fourchotte
a, Jean Guillaume Feron
a, Philippe Morice
n, Eric Deutsch
n, Pauline Wimberger
o, Jean-Marc Classe
p, Noreen Gleeson
q, Heiko von der Leyen
r, Mathieu Minsat
a, Coraline Dubot
a, Pierre Gestraud
a, Attila Kereszt
s, Istvan Nagy
s, Balazs Balint
s, Els Berns
t, Ekaterina Jordanova
e, Nicolas de Saint-Jorre
u, Alexia Savignoni
a, Nicolas Servant
a, Philippe Hupe
a, Leanne de Koning
a, Pierre Fumoleau
a, Roman Rouzier
a, Maud Kamal
a
Suzy Scholl
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Suzy Scholl
Marina Popovic
bGynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia
Find articles by Marina Popovic
Anne de la Rochefordiere
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Anne de la Rochefordiere
Elodie Girard
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Elodie Girard
Sylvain Dureau
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Sylvain Dureau
Aljosa Mandic
vFaculty of Medicine Novi Sad, University of Novi Sad, Serbia
Find articles by Aljosa Mandic
Katarina Koprivsek
bGynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia
vFaculty of Medicine Novi Sad, University of Novi Sad, Serbia
Find articles by Katarina Koprivsek
Marius Craina
dUniversity of Medicine and Pharmacy "Victor Babeș", Romania
Find articles by Marius Craina
Madalin Margan
dUniversity of Medicine and Pharmacy "Victor Babeș", Romania
Find articles by Madalin Margan
Sanne Samuels
eCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Find articles by Sanne Samuels
Henry Zijlmans
eCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Find articles by Henry Zijlmans
Gemma Kenter
eCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Find articles by Gemma Kenter
Goran Malenkovic
vFaculty of Medicine Novi Sad, University of Novi Sad, Serbia
Find articles by Goran Malenkovic
Branislav Djuran
bGynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia
Find articles by Branislav Djuran
Anne Floquet
gChirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France
Find articles by Anne Floquet
Delphine Garbay
gChirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France
Find articles by Delphine Garbay
Frédéric Guyon
gChirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France
Find articles by Frédéric Guyon
Charlotte Ngo
iService de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France
Find articles by Charlotte Ngo
Fabrice Lecuru
iService de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France
Find articles by Fabrice Lecuru
Eleonor Rivin del Campo
jDepartment of Radiation Oncology, Tenon University Hospital, Hôpitaux Universitaires Est Parisien, Sorbonne University Medical Faculty, Paris, France
Find articles by Eleonor Rivin del Campo
Frédéric Marchal
lDépartement de chirurgie, CRAN, UMR 7039, Université de Lorraine, CNRS, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne - CS 30519 54519, Vandoeuvre-les-Nancy Cedex, France
Find articles by Frédéric Marchal
Nathalie Mesgouez-Nebout
mInstitut de cancérologie de l'Ouest – site Paul Papin (ICO) 15, Rue André Boquel, 49055 Angers, France
Find articles by Nathalie Mesgouez-Nebout
Virginie Fourchotte
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Virginie Fourchotte
Jean Guillaume Feron
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Jean Guillaume Feron
Pauline Wimberger
oDepartment of Gynecology and Obstetrics, Universitätsklinikum Carl Gustav Carus; an der Technischen Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany
Find articles by Pauline Wimberger
Heiko von der Leyen
rHannover Clinical Trial Center GmbH, Germany
Find articles by Heiko von der Leyen
Mathieu Minsat
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Mathieu Minsat
Coraline Dubot
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Coraline Dubot
Pierre Gestraud
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Pierre Gestraud
Attila Kereszt
sSeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary
Find articles by Attila Kereszt
Istvan Nagy
sSeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary
Find articles by Istvan Nagy
Balazs Balint
sSeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary
Find articles by Balazs Balint
Ekaterina Jordanova
eCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Find articles by Ekaterina Jordanova
Alexia Savignoni
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Alexia Savignoni
Nicolas Servant
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Nicolas Servant
Philippe Hupe
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Philippe Hupe
Leanne de Koning
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Leanne de Koning
Pierre Fumoleau
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Pierre Fumoleau
Roman Rouzier
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Roman Rouzier
Maud Kamal
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
Find articles by Maud Kamal
aInstitut Curie, PSL Research University, Department of Drug Development and Innovation, France
bGynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia
cPublica Institutul Oncologic, Republic of Moldova
dUniversity of Medicine and Pharmacy "Victor Babeș", Romania
eCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
fHannover Medical School, Germany
gChirurgie onco-gynécologique and Oncology, Institut Bergonié, Centre Régional de Lutte contre le Cancer Bordeaux-Aquitaine, France
hCentre Val d'Aurelle, France
iService de chirurgie cancérologique gynécologique et du sein, Hôpital Européen Georges Pompidou, APHP et faculté de médecine, Université Paris Descartes, France
jDepartment of Radiation Oncology, Tenon University Hospital, Hôpitaux Universitaires Est Parisien, Sorbonne University Medical Faculty, Paris, France
kCentre Georges François Leclerc, France
lDépartement de chirurgie, CRAN, UMR 7039, Université de Lorraine, CNRS, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne - CS 30519 54519, Vandoeuvre-les-Nancy Cedex, France
mInstitut de cancérologie de l'Ouest – site Paul Papin (ICO) 15, Rue André Boquel, 49055 Angers, France
nGustave Roussy, France
oDepartment of Gynecology and Obstetrics, Universitätsklinikum Carl Gustav Carus; an der Technischen Universität Dresden, Fetscherstraße 74, 01307 Dresden, Germany
pRené Gauducheau, France
qSt James/Trinity College, Ireland
rHannover Clinical Trial Center GmbH, Germany
sSeqOmics Biotechnology Ltd, Vallalkozok utja 7, Morahalom, Hungary
tErasmus MC, The Netherlands
uQuanticsoft, France
vFaculty of Medicine Novi Sad, University of Novi Sad, Serbia
⁎
Corresponding author at: Department of Drug Development and Innovation, Institut Curie, 26, rue d'Ulm, Paris 75005, France. suzy.scholl@curie.fr
Collection date 2020 Jul.
© 2020 The Author(s)
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PMCID: PMC7341345 PMID: 32650273
This corrects the article "Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome" in volume 43 on page 253.